Mainz Biomed

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue
$214
$214
$181
$248
Gross Profit
134
134
87
148
EBITDA
-4,693
-5,437
-7,903
EBIT
-4,933
-5,640
-8,251
Net Income
-5,183
-5,183
-6,299
-8,251
Net Change In Cash
214
214
181
248
Free Cash Flow
-4,916
-4,916
-6,618
-5,242
Cash
7,070
7,070
9,320
10,911
Basic Shares
17,681
21,165
15,967
14,915

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$895
$529
$577
$493
Gross Profit
509
182
177
123
EBITDA
-25,011
-25,718
-11,280
-257
EBIT
-26,045
-26,177
-11,490
-410
Net Income
-26,295
-26,452
-12,072
-886
Net Change In Cash
895
529
577
493
Free Cash Flow
-23,837
-15,428
-3,237
-478
Cash
7,070
17,141
8,727
122
Basic Shares
16,242
14,157
7,210
5,607

Earnings Calls

Quarter EPS
2024-03-31
-$0.24
2023-12-31
-$0.24
2023-09-30
-$0.39
2023-06-30
-$0.56